Thomas Gillespie
Papers
2
Total Citations
15
H-Index
1
About
Dr. Thomas Gillespie is a pioneering surgeon whose work sits at the intersection of robotic surgery, vascular injury management, and hemostatic technology. His research has fundamentally advanced the safety and efficacy of minimally invasive procedures, particularly in high-stakes scenarios. Dr. Gillespie is best known for his landmark 2019 study, "REBOA as a rescue strategy for catastrophic vascular injury during robotic surgery," which has garnered 14 citations and established a critical protocol for managing life-threatening hemorrhages in the operating room. This work has been instrumental in expanding the boundaries of what is achievable robotically, providing surgeons with a life-saving tool when complications arise. More recently, his 2025 randomized controlled trial on Arista™ hemostatic agent in robotic ventral hernia repair, though early in its citation life, signals his continued commitment to refining surgical outcomes through rigorous evidence. Dr. Gillespie’s contributions not only enhance patient safety but also empower the next generation of robotic surgeons to operate with greater confidence and precision.
Research Focus
Key Achievements
Top Papers
- 1
- 2